US Patent Issued to IMMUNE MACRO-BIOTIC TECHNOLOGY UK on Nov. 4 for "Controlling a pathogen's resistance to immune surveillance" (British Inventor)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,670, issued on Nov. 4, was assigned to IMMUNE MACRO-BIOTIC TECHNOLOGY UK Ltd. (Devon, Great Britain).

"Controlling a pathogen's resistance to immune surveillance" was invented by Christopher Jeremy Leonard (Devon, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pathogen's resistance to immune surveillance is controlled using a controlled amount of Cytokine IL-10."

The patent was filed on March 11, 2021, under Application No. 17/198,562.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&c...